Johnson, RW, Rice, ASC. Clinical practice: Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–1533.CrossRefGoogle ScholarPubMed

Sampathkumar, P, Drage, LA, Martin, DP. Herpes zoster (Shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274–280.CrossRefGoogle ScholarPubMed

Insinga, RP, Itzler, RF, Pellissier, JM, Saddier, P, Nikas, AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748–753.CrossRefGoogle Scholar

Massengill, JS, Kittredge, JL. Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider. J Pain Res. 2014;7:125–132.CrossRefGoogle ScholarPubMed

Johnson, BH, Palmer, L, Gatwood, J et al. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis. 2015;15(1):1–5.CrossRefGoogle ScholarPubMed

Forbes, HJ, Thomas, SL, Smeeth, L et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30–54.CrossRefGoogle ScholarPubMed

Head, H, Campbell, AW. The pathology of herpes zoster and its bearing on sensory localisation. Brain. 1900;23(3):353–362.CrossRefGoogle Scholar

Hadley, GR, Gayle, JA, Ripoll, J et al. Post-herpetic neuralgia: A review. Curr Pain Headache Rep. 2016;20(3):17. doi: 10.1007/s11916-016-0548-x.CrossRefGoogle ScholarPubMed

Fields, HL, Rowbotham, M, Baron, R. Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5(4):209–227.CrossRefGoogle ScholarPubMed

Garry, EM, Delaney, A, Anderson, HA et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain. 2005;118(1–2):97–111.CrossRefGoogle ScholarPubMed

Watson, CPN, Deck, JH, Morshead, C, Van der Kooy, D, Evans, RJ. Post-herpetic neuralgia: Further post-mortem studies of cases with and without pain. Pain. 1991;44(2):105–117.CrossRefGoogle ScholarPubMed

Woolf, CJ, Max, MB. Mechanism-based pain diagnosis: Issues for analgesic drug development. Anesthesiology. 2001;95(1):241–249.CrossRefGoogle ScholarPubMed

Nalamachu, S, Morley-Forster, P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29(11):863–869.CrossRefGoogle ScholarPubMed

Dworkin, RH, Gnann, JW, Oaklander, AL et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(Suppl 1):37–44.CrossRefGoogle ScholarPubMed

Dooling, KL, Guo, A, Patel, M et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. Morb Mortal Wkly Rep. 2018;67(3):103–108.CrossRefGoogle ScholarPubMed

Finnerup, NB, Attal, N, Haroutounian, S et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173.CrossRefGoogle ScholarPubMed

Dworkin, RH, O’Connor, AB, Kent, J et al. International association for the study of pain neuropathic pain special interest group. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013;154(11):2249–2261.CrossRefGoogle Scholar

Max, MB. Treatment of post-herpetic neuralgia: Antidepressants. Ann Neurol. 1994;35(Suppl 1):S50–S53.CrossRefGoogle ScholarPubMed

Liang, J, Liu, X, Zheng, J, Yu, S. Effect of amitriptyline on tetrodotoxin-resistant Na_v1.9 currents in nociceptive trigeminal neurons. Mol Pain. 2013;9:31. doi: 10.1186/1744-8069-9-31.CrossRefGoogle ScholarPubMed

Yalcin, I, Choucair-Jaafar, N, Benbouzid, M et al. β2-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol. 2009;65(2):218–225.CrossRefGoogle Scholar

Dworkin, RH, O’Connor, AB, Audette, J et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc. 2010;85(Suppl 3):S3–S14.CrossRefGoogle ScholarPubMed

Attal, N. Pharmacological treatments of neuropathic pain: The latest recommendations. Rev Neurol (Paris). 2019;175(1–2):46–50.CrossRefGoogle ScholarPubMed

Bohnert, AS, Ilgen, MA, Trafton, JA et al. Trends and regional variation in opioid overdose mortality among veterans health administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605–612. doi: 10.1097/AJP.0000000000000011.CrossRefGoogle ScholarPubMed

Johnson, RW, Rice, ASC. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–1533.CrossRefGoogle ScholarPubMed

Dworkin, RH, O’Connor, AB, Backonja, M et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007;132(3):237–251.CrossRefGoogle ScholarPubMed

Finnerup, NB, Otto, M, McQuay, HJ, Jensen, TS, Sindrup, SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005;118(3):289–305.CrossRefGoogle ScholarPubMed

McNicol, ED, Midbari, A, Eisenberg, E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;(8):CD006146. doi: 10.1002/14651858.CD006146.pub2.CrossRefGoogle ScholarPubMed

Bernstein, JE, Korman, NJ, Bickers, DR, Dahl, MV, Millikan, LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989;21(2 Pt 1):265–270.CrossRefGoogle ScholarPubMed

Backonja, MM, Malan, TP, Vanhove, GF, Tobias, JK. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind, controlled study with an open-label extension. Pain Med. 2010;11(4):600–608.CrossRefGoogle ScholarPubMed

Watson, CP, Tyler, KL, Bickers, DR et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15(3):510–526.Google ScholarPubMed

Anand, P, Bley, K. Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 patch. Br J Anaesth. 2011;107:490–502.CrossRefGoogle ScholarPubMed

Derry, S, Rice, AS, Cole, P, Tan, T, Moore, RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane database Syst Rev. 2017;1:CD007393.Google ScholarPubMed

de León-Casasola, OA, Mayoral, V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: A reappraisal of the clinical evidence. J Pain Res. 2016;9:67–79.CrossRefGoogle ScholarPubMed

Derry, S, Wiffen, PJ, Moore, RA, Quinlan, J. Topical lidocaine for neuropathic pain in adults. Cochrane database Syst Rev. 2014;2014(7):CD010958.Google ScholarPubMed

Cui, M, Khanijou, S, Rubino, J, Aoki, KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107(1):125–133.CrossRefGoogle ScholarPubMed

Lin, C-S, Lin, Y-C, Lao, H-C, Chen, C-C. Interventional treatments for postherpetic neuralgia: A systematic review. Pain Physician. 2019;22(3):209–228.CrossRefGoogle ScholarPubMed

Sluka, KA, Walsh, D. Transcutaneous electrical nerve stimulation: Basic science mechanisms and clinical effectiveness. J Pain. 2003;4(3):109–121.CrossRefGoogle ScholarPubMed

Barbarisi, M, Pace, MC, Passavanti, MB et al. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 2010;26(7):567–572.CrossRefGoogle ScholarPubMed

Xû, G, Xú, G, Feng, Y, Tang, WZ, Lv, ZW. Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia. Am J Phys Med Rehabil. 2014;93(4):287–298.CrossRefGoogle ScholarPubMed

Wu, CL, Marsh, A, Dworkin, RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000;87(2):121–129.CrossRefGoogle ScholarPubMed

Bruehl, S. Complex regional pain syndrome. BMJ. 2016;38:82–86.Google Scholar

Van Velzen, GAJ, Perez, RSGM, Van Gestel, MA et al. Health-related quality of life in 975 patients with complex regional pain syndrome type 1. Pain. 2014;155(3):629–634.CrossRefGoogle ScholarPubMed

Sandroni, P, Benrud-Larson, LM, McClelland, RL, Low, PA. Complex regional pain syndrome type I: Incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103:199–207.CrossRefGoogle ScholarPubMed

Elsharydah, A, Loo, NH, Minhajuddin, A, Kandil, ES. Complex regional pain syndrome type 1 predictors: Epidemiological perspective from a national database analysis. J Clin Anesth. 2017;39:34–37.CrossRefGoogle ScholarPubMed

de Mos, M, de Bruijn, AGJ, Huygen, FJPM et al. The incidence of complex regional pain syndrome: A population-based study. Pain. 2007;129(1–2):12–20.CrossRefGoogle ScholarPubMed

Rewhorn, MJ, Leung, AH, Gillespie, A, Moir, JS, Miller, R. Incidence of complex regional pain syndrome after foot and ankle surgery. J Foot Ankle Surg. 2014;53(3):256–258.CrossRefGoogle ScholarPubMed

Jellad, A, Salah, S, Ben Salah Frih, Z. Complex regional pain syndrome type I: Incidence and risk factors in patients with fracture of the distal radius. Arch Phys Med Rehabil. 2014;95(3):487–492.CrossRefGoogle ScholarPubMed

Bean, DJ, Johnson, MH, Kydd, RR. Relationships between psychological factors, pain, and disability in complex regional pain syndrome and low back pain. Clin J Pain. 2014;30(8):647–653.CrossRefGoogle ScholarPubMed

Beerthuizen, A, Stronks, DL, Van’T Spijker, A et al. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): Prospective study on 596 patients with a fracture. Pain. 2012;153(6):1187–1192.CrossRefGoogle ScholarPubMed

Birklein, F, Schlereth, T. Complex regional pain syndrome: Significant progress in understanding. Pain. 2015;156:S94–S103.CrossRefGoogle ScholarPubMed

Marinus, J, Moseley, GL, Birklein, F et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 2011;10(7):637–648.CrossRefGoogle ScholarPubMed

Shi, X, Wang, L, Li, X et al. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes. Anesth Analg. 2011;113(1):175–183.CrossRefGoogle ScholarPubMed

Sahbaie, P, Shi, X, Guo, TZ et al. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain. 2009;145(3):341–349.CrossRefGoogle ScholarPubMed

Oaklander, AL, Fields, HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65(6):629–638.CrossRefGoogle ScholarPubMed

Albrecht, PJ, Hines, S, Eisenberg, E et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain. 2006;120(3):244–266.CrossRefGoogle ScholarPubMed

van der Laan, L, ter Laak, HJ, Gabreëls-Festen, A, Gabreëls, F, Goris, RJ. Complex regional pain syndrome type I (RSD): Pathology of skeletal muscle and peripheral nerve. Neurology. 1998;51(1):20–25.CrossRefGoogle ScholarPubMed

Reinersmann, A, Maier, C, Schwenkreis, P, Lenz, M. Complex regional pain syndrome: More than a peripheral disease. Pain Manag. 2013;3(6):495–502.CrossRefGoogle ScholarPubMed

Hotta, J, Saari, J, Koskinen, M et al. Abnormal brain responses to action observation in complex regional pain syndrome. J Pain. 2017;18(3):255–265.CrossRefGoogle ScholarPubMed

Goebel, A, Blaes, F. Complex regional pain syndrome, prototype of a novel kind of autoimmune disease. Autoimmun Rev. 2013;12(6):682–686.CrossRefGoogle ScholarPubMed

Guo, T, Shi, X, Li, W et al. Passive transfer autoimmunity in a mouse model of complex regional pain syndrome. Pain. 2017;158(12):2410–2421. doi: 10.1097/j.pain.0000000000001046.CrossRefGoogle Scholar

Merskey, H, Bogduk, N. Classification of chronic pain: IASP pain terminology. 1994. www.iasp-pain.org/publications/free-ebooks/classification-of-chronic-pain-second-edition-revised/.Google Scholar

Harden, NR, Bruehl, S, Perez, RSGM, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome. Pain. 2010;150(2):268–274. doi: 10.1016/j.pain.2010.04.030.CrossRefGoogle ScholarPubMed

Harden, RN, Bruehl, S, Perez, RSGM et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010;150(2):268–274.CrossRefGoogle ScholarPubMed

Bruehl, S, Harden, RN, Galer, BS et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain. 1999;81(1–2):147–154.CrossRefGoogle ScholarPubMed

Oerlemans, HM, Oostendorp, RAB, de Boo, T et al. Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I. Arch Phys Med Rehabil. 2000;81(1):49–56.CrossRefGoogle ScholarPubMed

Rome, L. The place of occupational therapy in rehabilitation strategies of complex regional pain syndrome: Comparative study of 60 cases. Hand Surg Rehabil. 2016;35(5):355–362.CrossRefGoogle ScholarPubMed

Oerlemans, HM, Oostendorp, RA, de Boo, T, Goris, RJ. Pain and reduced mobility in complex regional pain syndrome I: Outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain. 1999;83(1):77–83.CrossRefGoogle ScholarPubMed

Smart, KM, Wand, BM, O’Connell, NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2016;2(2):CD010853. doi: 10.1002/14651858.CD010853.pub2.Google ScholarPubMed

Kemler, MA, Barendse, GA, van Kleef, M et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343(9):618–624.CrossRefGoogle ScholarPubMed

Kumar, K, Rizvi, S, Bnurs, SB. Spinal cord stimulation is effective in management of complex regional pain syndrome I: Fact or fiction. Neurosurgery. 2011;69(3):566–578.CrossRefGoogle ScholarPubMed

Connolly, SB, Prager, JP, Harden, RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943–969.CrossRefGoogle ScholarPubMed

Penn, R, Kroin, J. Intrathecal baclofen alleviates spinal cord spasticity. Lancet. 1984;323:1078. doi: 10.1016/s0140-6736(84)91487-9.CrossRefGoogle Scholar

Melcangic, M, Bowery, NG. GABA and its receptors in the spinal cord. Trends Pharmacol Sci. 1996;17(12):457–462.CrossRefGoogle Scholar

van Rijn, MA, Munts, AG, Marinus, J et al. Intrathecal baclofen for dystonia of complex regional pain syndrome. Pain. 2009;143(1–2):41–47.CrossRefGoogle ScholarPubMed

Ferraro, MC, Cashin, AG, Wand, BM, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome: An overview of systematic reviews (Review). Cochrane Database Syst Rev. 2013;6(6): CD009416. doi: 10.1002/14651858.CD009416.pub3.Google Scholar

Chevreau, M, Romand, X, Gaudin, P, Juvin, R, Baillet, A. Bisphosphonates for treatment of complex regional pain syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo. Jt Bone Spine. 2017;84(4):393–399.CrossRefGoogle ScholarPubMed

O’Connell, NE, Wand, BM, McAuley, J, Marston, L, Moseley, GL. Interventions for treating pain and disability in adults with complex regional pain syndrome: An overview of systematic reviews. In O’Connell, NE, ed. Cochrane batabase of systematic reviews. John Wiley; 2013.Google Scholar

Goebel, A, Bisla, J, Carganillo, R et al. Low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome: A randomized trial. Ann Intern Med. 2017;167(7):476–483.CrossRefGoogle ScholarPubMed

Goebel, A, Bisla, J, Carganillo, R et al. A randomised placebo-controlled Phase III multicentre trial: Low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial). NIHR Journals Library. 2017. PMID: 29144634.CrossRefGoogle Scholar

Jaiman, A, Lokesh, M, Neogi, DS. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg. 2011;17:207. doi: 10.1016/j.fas.2010.05.008.CrossRefGoogle ScholarPubMed

Shibuya, N, Humphers, JM, Agarwal, MR, Jupiter, DC. Efficacy and safety of high-dose vitamin C on complex regional pain syndrome in extremity trauma and surgery: Systematic review and meta-analysis. J Foot Ankle Surg. 2013;52(1):62–66.CrossRefGoogle ScholarPubMed

Zollinger, PE, Tuinebreijer, WE, Breederveld, RS, Kreis, RW. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am. 2007;89(7):1424–1431.CrossRefGoogle ScholarPubMed

Meena, S, Sharma, P, Gangary, SK, Chowdhury, B. Role of vitamin C in prevention of complex regional pain syndrome after distal radius fractures: A meta-analysis. Eur J Orthop Surg Traumatol. 2015;25(4):637–641.CrossRefGoogle ScholarPubMed

Malay, S, Chung, KC. Testing the validity of preventing complex regional pain syndrome with vitamin C after distal radius fracture. J Hand Surg Am. 2014;39(11):2251–2257.CrossRefGoogle ScholarPubMed

Kim, JH, Kim, YC, Nahm, FS, Lee, PB. The therapeutic effect of vitamin C in an animal model of complex regional pain syndrome produced by prolonged hindpaw ischemia-reperfusion in rats. Int J Med Sci. 2017;14(1):97–101.CrossRefGoogle Scholar

Midbari, A, Suzan, E, Adler, T et al. Amputation in patients with complex regional pain syndrome: A comparative study between amputees and non-amputees with intractable disease. Bone Joint J. 2016;98-B(4):548–554.CrossRefGoogle ScholarPubMed

Borhade, MB, Kondamudi, NP. Sickle cell crisis. In StatPearls. 2022. pp. 365–379. Treasure Island (FL): StatPearls Publishing.Google Scholar

Sundd, P, Gladwin, MT, Novelli, EM. Pathophysiology of sickle cell disease. Annu Rev Pathol Mech Dis. 2019;14(1):421058352. doi: 10.1146/annurev-pathmechdis-012418-012838.CrossRefGoogle ScholarPubMed

Dampier, C, Palermo, TM, Darbari, DS et al. AAPT diagnostic criteria for chronic sickle cell disease pain. J Pain. 2017;18(5):490–498.CrossRefGoogle ScholarPubMed

Brandow, AM, DeBaun, MR. Key components of pain management for children and adults with sickle cell disease. Hematol Oncol Clin North Am. 2018;32(3):535–550.CrossRefGoogle ScholarPubMed

Strouse, J. Sickle cell disease. Handb Clin Neurol. 2016;138:311–324.CrossRefGoogle ScholarPubMed

Azar, S, Wong, TE. Sickle cell disease: A brief update. Med Clin North Am. 2017;101(2):375–393.CrossRefGoogle ScholarPubMed

Cacciotti, C, Vaiselbuh, S, Romanos-Sirakis, E. Pain management for sickle cell disease in the pediatric emergency department: Medications and hospitalization trends. Clin Pediatr. 2017;56:1109–1114.CrossRefGoogle ScholarPubMed

Tran, H, Gupta, M, Gupta, K. Targeting novel mechanisms of pain in sickle cell disease. Blood. 2017;130(22):2377–2385.CrossRefGoogle ScholarPubMed

Nobrega, R, Sheehy, KA, Lippold, C et al. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease. Pediatr Res. 2018;83(2):445–454.CrossRefGoogle ScholarPubMed

Riley, TR, Boss, A, McClain, D, Riley, TT. Review of medication therapy for the prevention of sickle cell crisis. Pharm Ther. 2018;43(7):417–437.Google ScholarPubMed

Lubega, FA, DeSilva, MS, Munube, D et al. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: A randomized controlled trial. Scand J Pain. 2018;18(1):19–27.CrossRefGoogle ScholarPubMed

Palm, N, Floroff, C, Hassig, TB, Boylan, A, Kanter, J. Low-dose ketamine infusion for adjunct management during vaso-occlusive episodes in adults with sickle cell disease: A case series. J Pain Palliat Care Pharmacother. 2018;32(1):20–26.CrossRefGoogle ScholarPubMed

Young, JR, Sawe, HR, Mfinanga, JA et al. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: Study protocol for a randomised controlled trial. BMJ Open. 2017;7(7):e017190.CrossRefGoogle ScholarPubMed

Kelly, GS, Stewart, RW, Strouse, JJ, Anders, JF. Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises. Am J Emerg Med. 2018;36(7):1305–1307. doi: 10.1016/j.ajem.2017.11.015.CrossRefGoogle ScholarPubMed

Rousseau, V, Morelle, M, Arriuberge, C et al. Efficacy and tolerance of lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle cell crises in children: A prospective multicenter clinical study. Pain Pract. 2018;18(6):788–797.CrossRefGoogle ScholarPubMed

Brittain, JE, Anea, C, Desai, P et al. Effect of eptifibatide on inflammation during acute pain episodes in sickle cell disease. Am J of Hematol. 2018;93:E99–E101.CrossRefGoogle ScholarPubMed

Bhatt, RR, Martin, SR, Evans, S et al. The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: A pilot study. J Pain Res. 2017;10:1635–1644.CrossRefGoogle ScholarPubMed

Agrawal, AK, Robertson, S, Litwin, L et al. Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease. Pediatr Blood Cancer. 2019;66(2):e27525. doi: 10.1002/pbc.27525.CrossRefGoogle ScholarPubMed

Palermo, TM, Zempsky, WT, Dampier, CD et al. iCanCope with sickle cell pain: Design of a randomized controlled trial of a smartphone and web-based pain self-management program for youth with sickle cell disease. Contemp Clin Trials. 2018;74:88–96.CrossRefGoogle ScholarPubMed

Palermo, TM, Dudeney, J, Santanelli, JP, Carletti, A, Zempsky, WT. Feasibility and acceptability of internet-delivered cognitive behavioral therapy for chronic pain in adolescents with sickle cell disease and their parents. J Pediatr Hematol Oncol. 2018;40(2):122–127.CrossRefGoogle ScholarPubMed

Urits, I, Lavin, C, Patel, M et al. Chronic pain following cosmetic breast surgery: A comprehensive review. Pain Ther. 2020;9:71–82. https://doi.org/10.1007/s40122-020-00150-.CrossRefGoogle ScholarPubMed

van Elk, N, Steegers, MA, van der Weij, LP et al. Chronic pain in women after breast augmentation: Prevalence, predictive factors and quality of life. Eur J Pain. 2009;13(6):660–661.CrossRefGoogle ScholarPubMed

Monib, S, Abdelaziz, MI. Epidemiology and predictive factors for persistent breast pain following breast-conserving surgery. Cureus. 2021;13(3):e14063. https://doi.org/10.7759/cureus.14063.Google ScholarPubMed

Wang, L, Cohen, JC, Devasenapathy, N et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: A systematic review and meta-analysis of observational studies. Br J Anaesth. 2020;125(3):346–357. https://doi.org/10.1016/j.bja.2020.04.088.CrossRefGoogle ScholarPubMed

Miaskowski, C, Cooper, B, Paul, SM et al. Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain. 2012;13(12):1172–1187. https://doi.org/10.1016/j.jpain.2012.09.013.CrossRefGoogle ScholarPubMed

Langford, DJ, Schmidt, B, Levine, JD et al. Preoperative breast pain predicts persistent breast pain and disability after breast cancer surgery. J Pain Symptom Manage. 2015;49(6):981–994. https://doi.org/10.1016/j.jpainsymman.2014.11.292.CrossRefGoogle ScholarPubMed

Fecho, K, Miller, NR, Merritt, SA et al. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009;10(4):708–715. https://doi.org/10.1111/j.1526-4637.2009.00611.x.CrossRefGoogle ScholarPubMed

Ducic, I, Seiboth, LA, Iorio, ML. Chronic postoperative breast pain: Danger zones for nerve injuries. Plast Reconstr Surg. 2011;127(1):41–46. https://doi.org/10.1097/PRS.0b013e3181f9587f.CrossRefGoogle ScholarPubMed

Fregoso, G, Wang, A, Tseng, K, Wang, J. Transition from acute to chronic pain: Evaluating risk for chronic postsurgical pain. Pain Physician. 2019;22(5):479–488.Google ScholarPubMed

Kokosis, G, Chopra, K, Darrach, H, Dellon, AL, Williams, EH. Re-visiting post-breast surgery pain syndrome: Risk factors, peripheral nerve associations and clinical implications. Gland Surg. 2019;8(4):407–415. https://doi.org/10.21037/gs.2019.07.05.CrossRefGoogle ScholarPubMed

Von Sperling, ML, Høimyr, H, Finnerup, K, Jensen, TS, Finnerup, NB. Persistent pain and sensory changes following cosmetic breast augmentation. Eur J Pain. 2011;15(3):328–332.CrossRefGoogle ScholarPubMed

Ducic, I, Zakaria, HM, Felder, JM, Fantus, S. Nerve injuries in aesthetic breast surgery: Systematic review and treatment options. Aesthetic Surg J. 2014;34(6):841–856.CrossRefGoogle ScholarPubMed

Waltho, D, Rockwell, G. Post-breast surgery pain syndrome: Establishing a consensus for the definition of post-mastectomy pain syndrome to provide a standardized clinical and research approach: A review of the literature and discussion. Can J Surg. 2016;59(5):342–350.CrossRefGoogle ScholarPubMed

Classification of Chronic Pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1–S226.Google Scholar

Couceiro, TC, Valença, MM, Raposo, MC, Orange, FA, Amorim, MM. Prevalence of post-mastectomy pain syndrome and associated risk factors: A cross-sectional cohort study. Pain Manag Nurs. 2014;15(4):731–737. https://doi.org/10.1016/j.pmn.2013.07.011.CrossRefGoogle ScholarPubMed

Chopra, K, Kokosis, G, Slavin, B, Williams, E, Dellon, AL. Painful complications after cosmetic surgery: Management of peripheral nerve injury. Aesthet Surg J. 2019;39(12):1427–1435. https://doi.org/10.1093/asj/sjy284.CrossRefGoogle ScholarPubMed

Massingill, J, Jorgensen, C, Dolata, J, Sehgal, AR. Myofascial massage for chronic pain and decreased upper extremity mobility after breast cancer surgery. Int J Ther Massage Bodyw Res Educ Pract. 2018;11(3):4–9.Google ScholarPubMed

Dowell, D, Haegerich, TM, Chou, R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA. 2016;315(15):1624–1645.CrossRefGoogle Scholar

Kulhari, S, Bharti, N, Bala, I, Arora, S, Singh, G. Efficacy of pectoral nerve block versus thoracic paravertebral block for postoperative analgesia after radical mastectomy: A randomized controlled trial. Br J Anaesth. 2016;117(3):382–386.CrossRefGoogle ScholarPubMed

Maloney, J, Wie, C, Pew, S et al. Post-thoracotomy pain syndrome. Curr Pain Headache Rep. 2022;26(9):677–681. https://doi.org/10.1007/s11916-022-01069-z.CrossRefGoogle ScholarPubMed

Khelemsky, Y, Noto, CJ. Preventing post-thoracotomy pain syndrome. Mt Sinai J Med. 2012;79(1):133–139. https://doi.org/10.1002/MSJ.21286.CrossRefGoogle ScholarPubMed

Hopkins, KG, Rosenzweig, M. Post-thoracotomy pain syndrome: Assessment and intervention. Clin J Oncol Nurs. 2012;16(4):365–370. https://doi.org/10.1188/12.CJON.365-370.CrossRefGoogle ScholarPubMed

Arends, S, Böhmer, AB, Poels, M et al. Post-thoracotomy pain syndrome: Seldom severe, often neuropathic, treated unspecific, and insufficient. Pain Rep. 2020;5(2):e810. https://doi.org/10.1097/PR9.0000000000000810.CrossRefGoogle ScholarPubMed

El-Hag-Aly, MA, Hagag, MG, Allam, HK. If post-thoracotomy pain is the target, integrated thoracotomy is the choice. Gen Thorac Cardiovasc Surg. 2019;67(11):955–961. https://doi.org/10.1007/S11748-019-01126-2/TABLES/4.CrossRefGoogle ScholarPubMed

Khalil, AE, Abdallah, NM, Bashandy, GM, Kaddah, TAH. Ultrasound-guided serratus anterior plane block versus thoracic epidural analgesia for thoracotomy pain. J Cardiothorac Vasc Anesth. 2017;31(1):152–158. https://doi.org/10.1053/J.JVCA.2016.08.023.CrossRefGoogle ScholarPubMed

Elsabeeny, WY, Ibrahim, MA, Shehab, NN, Mohamed, A, Wadod, MA. Serratus anterior plane block and erector spinae plane block versus thoracic epidural analgesia for perioperative thoracotomy pain control: A randomized controlled study. J Cardiothorac Vasc Anesth. 2021;35(10):2928–2936. https://doi.org/10.1053/J.JVCA.2020.12.047.CrossRefGoogle ScholarPubMed

Reyad, RM, Shaker, EH, Ghobrial, HZ et al. The impact of ultrasound-guided continuous serratus anterior plane block versus intravenous patient-controlled analgesia on the incidence and severity of post-thoracotomy pain syndrome: A randomized, controlled study. Eur J Pain. 2020;24(1):159–170. https://doi.org/10.1002/EJP.1473.CrossRefGoogle ScholarPubMed

Gaber, S, Saleh, E, Elshaikh, S et al. Role of perioperative pregabalin in the management of acute and chronic post-thoracotomy pain. Open Access Maced J Med Sci. 2019;7(12):1974–1978. https://doi.org/10.3889/OAMJMS.2019.556.CrossRefGoogle ScholarPubMed

Fawzi, HM, El-Tohamy, SA. Effect of perioperative oral pregabalin on the incidence of post-thoracotomy pain syndrome. Ain-Shams J Anaesthesiology. 2014;7(2):143. https://doi.org/10.4103/1687-7934.133350.CrossRefGoogle Scholar

Mendola, C, Cammarota, G, Netto, R et al. S(+)-ketamine for control of perioperative pain and prevention of post thoracotomy pain syndrome: A randomized, double-blind study. Minerva Anestesiol. 2012;78(7):757–766. https://pubmed.ncbi.nlm.nih.gov/22441361/.Google ScholarPubMed

Israel, JE, St Pierre, S, Ellis, E et al. Ketamine for the treatment of chronic pain: A comprehensive review. Health Psychol Res. 2021;9(1):1–12. https://doi.org/10.52965/001C.25535.CrossRefGoogle ScholarPubMed

Abd-Elsayed, A, Lee, S, Jackson, M. Radiofrequency ablation for treating resistant intercostal neuralgia. Ochsner J. 2018;18(1):91–93. https://doi.org/10.1043/TOJ-17-0043.Google ScholarPubMed

Engel, AJ. Utility of intercostal nerve conventional thermal radiofrequency ablations in the injured worker after blunt trauma. Pain Physician. 2012;15:E711–E718. https://pubmed.ncbi.nlm.nih.gov/22996865/.CrossRefGoogle ScholarPubMed

Theodosiadis, P, Grosomanidis, V, Samoladas, E, Chalidis, BE. Subcutaneous targeted neuromodulation technique for the treatment of intractable chronic postthoracotomy pain. J Clin Anesth. 2010;22(8):638–641. https://doi.org/10.1016/J.JCLINANE.2009.10.018.CrossRefGoogle ScholarPubMed

McJunkin, TL, Berardoni, N, Lynch, PJ, Amrani, J. An innovative case report detailing the successful treatment of post-thoracotomy syndrome with peripheral nerve field stimulation. Neuromodulation Technol Neural Interface. 2010;13(4):311–314. https://doi.org/10.1111/J.1525-1403.2010.00277.X.CrossRefGoogle ScholarPubMed

Graybill, J, Conermann, T, Kabazie, AJ, Chandy, S. Spinal cord stimulation for treatment of pain in a patient with post thoracotomy pain syndrome. Pain Physician. 2011;14(5):441–445. https://pubmed.ncbi.nlm.nih.gov/21927048/.CrossRefGoogle Scholar

Wininger, KL, Bester, ML, Deshpande, KK. Spinal cord stimulation to treat postthoracotomy neuralgia: Non-small-cell lung cancer: A case report. Pain Manag Nurs. 2012;13(1):52–59. https://doi.org/10.1016/J.PMN.2011.11.001.CrossRefGoogle ScholarPubMed

lo Bianco, G, Papa, A, Gazzerro, G et al. Dorsal root ganglion stimulation for chronic postoperative pain following thoracic surgery: A pilot study. Neuromodulation. 2021;24(4):774–778. https://doi.org/10.1111/NER.13265.CrossRefGoogle ScholarPubMed

Ghasemi, N, Razavi, S, Nikzad, E. Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1–10. https://doi.org/10.22074/cellj.2016.4867.Google ScholarPubMed

Monteleone, F, Nicoletti, CG, Stampanoni Bassi, M et al. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. J Neuroimmunol. 2018;314:89–93. https://doi.org/10.1016/j.jneuroim.2017.11.012.CrossRefGoogle ScholarPubMed

Kalia, LV, O’Connor, PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler. 2005;11(3):322–327. https://doi.org/10.1191/1352458505ms1168oa.CrossRefGoogle ScholarPubMed

Young, J, Amatya, B, Galea, MP, Khan, F. Chronic pain in multiple sclerosis: A 10-year longitudinal study. Scand J Pain. 2017;16:198–203. https://doi.org/10.1016/j.sjpain.2017.04.070.CrossRefGoogle ScholarPubMed

Fallata, A, Salter, A, Tyry, T, Cutter, GR, Marrie, RA. Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis. Int J MS Care. 2017;19(5):240–246. https://doi.org/10.7224/1537-2073.2016-065.CrossRefGoogle ScholarPubMed

Zakrzewska, JM, Wu, J, Brathwaite, TSL. A systematic review of the management of trigeminal neuralgia in patients with multiple sclerosis. World Neurosurg. 2018;111:291–306. https://doi.org/10.1016/j.wneu.2017.12.147.CrossRefGoogle ScholarPubMed

Xu, Z, Mathieu, D, Heroux, F et al. Stereotactic radiosurgery for trigeminal neuralgia in patients with multiple sclerosis: A multicenter study. Neurosurgery. 2019;84(2):499–505. https://doi.org/10.1093/neuros/nyy142.CrossRefGoogle ScholarPubMed

La Mantia, L, Prone, V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015;36(Suppl 1):75–78. https://doi.org/10.1007/s10072-015-2146-9.CrossRefGoogle ScholarPubMed

Husain, F, Pardo, G, Rabadi, M. Headache and its management in patients with multiple sclerosis. Curr Treat Options Neurol. 2018;20(4):10. https://doi.org/10.1007/s11940-018-0495-4.CrossRefGoogle ScholarPubMed

Murphy, KL, Bethea, JR, Fischer, R. Neuropathic pain in multiple sclerosis: Current therapeutic intervention and future treatment perspectives. In: Zagon, IS, McLaughlin, PJ, eds. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Brisbane: Codon Publications. 2017.Google ScholarPubMed

Solaro, C, Cella, M, Signori, A et al. Identifying neuropathic pain in patients with multiple sclerosis: A cross-sectional multicenter study using highly specific criteria. J Neurol. 2018;265(4):828–835. https://doi.org/10.1007/s00415-018-8758-2.CrossRefGoogle ScholarPubMed

Heitmann, H, Biberacher, V, Tiemann, L et al. Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler. 2016;22(9):1224–1230. https://doi.org/10.1177/1352458515613643.CrossRefGoogle ScholarPubMed

Rice, J, Cameron, M. Cannabinoids for treatment of MS symptoms: State of the evidence. Curr Neurol Neurosci Rep. 2018;18(8):50. https://doi.org/10.1007/s11910-018-0859-x.CrossRefGoogle ScholarPubMed

Landa, L, Jurica, J, Sliva, J, Pechackova, M, Demlova, R. Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;162(1):18–25. https://doi.org/10.5507/bp.2018.007.CrossRefGoogle ScholarPubMed

Jitpakdee, T, Mandee, S. Strategies for preventing side effects of systemic opioid in postoperative pediatric patients. Paediatr Anaesth. 2014;24(6):561–568. https://doi.org/10.1111/pan.12420.CrossRefGoogle ScholarPubMed

Demaneuf, T, Aitken, Z, Karahalios, A et al. Effectiveness of exercise interventions for pain reduction in people with multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2019;100(1):128–139. https://doi.org/10.1016/j.apmr.2018.08.178.CrossRefGoogle ScholarPubMed

Kahraman, T, Ozdogar, AT, Yigit, P et al. Feasibility of a 6-month yoga program to improve the physical and psychosocial status of persons with multiple sclerosis and their family members. Explore (NY). 2018;14(1):36–43. https://doi.org/10.1016/j.explore.2017.07.006.CrossRefGoogle ScholarPubMed

Abboud, H, Hill, E, Siddiqui, J, Serra, A, Walter, B. Neuromodulation in multiple sclerosis. Mult Scler. 2017;23(13):1663–1676. https://doi.org/10.1177/1352458517736150.CrossRefGoogle ScholarPubMed

Urits, I, Adamian, L, Fiocchi, J et al. Advances in the understanding and management of chronic pain in multiple sclerosis: A comprehensive review. Curr Pain Headache Rep. 2019;23(8):59. https://doi.org/10.1007/s11916-019-0800-2.CrossRefGoogle ScholarPubMed

Krigger, KW. Cerebral palsy: An overview. Am Fam Physician. 2006;73(1):91–100. www.aafp.org/pubs/afp/issues/2006/0101/p91.html.Google ScholarPubMed

Bonellie, S, Currie, D, Chalmers, J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol. 2022;47(9):587–591. https://doi.org/10.1111/J.1469-8749.2005.TB01208.X.CrossRefGoogle Scholar

Graham, HK, Rosenbaum, P, Paneth, N et al. Cerebral palsy. Nat Rev Dis Primers. 2016;2(1):1–25. https://doi.org/10.1038/nrdp.2015.82.Google ScholarPubMed

Guillamón, N, Nieto, R, Pousada, M et al. Quality of life and mental health among parents of children with cerebral palsy: The influence of self-efficacy and coping strategies. J Clin Nurs. 2013;22(11–12):1579–1590. https://doi.org/10.1111/JOCN.12124.CrossRefGoogle ScholarPubMed

Wimalasundera, N, Stevenson, VL. Cerebral palsy. Pract Neurol. 2016;16(3):184–194. https://doi.org/10.1136/PRACTNEUROL-2015-001184.CrossRefGoogle ScholarPubMed

Byrne, R, Noritz, G, Maitre, NL. Implementation of early diagnosis and intervention guidelines for cerebral palsy in a high-risk infant follow-up clinic. Pediatr Neurol. 2017;76:66–71. https://doi.org/10.1016/J.PEDIATRNEUROL.2017.08.002.CrossRefGoogle Scholar

Vitrikas, K, Dalton, H, Breish, D. Cerebral palsy: An overview. Am Fam Physician. 2020;101(4):213–220. https://doi.org/10.4274/hamidiyemedj.galenos.2021.72792.Google ScholarPubMed

Himmelmann, K, Ahlin, K, Jacobsson, B, Cans, C, Thorsen, P. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand. 2011;90(10):1070–1081 https://doi.org/10.1111/j.1600-0412.2011.01217.x.CrossRefGoogle ScholarPubMed

Bax, M, Tydeman, C, Flodmark, O. Clinical and MRI correlates of cerebral palsy: The European cerebral palsy study. JAMA. 2006;296(13):1602–1608. https://doi.org/10.1001/JAMA.296.13.1602.CrossRefGoogle ScholarPubMed

Pass, RF, Fowler, KB, Boppana, SB, Britt, WJ, Stagno, S. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol. 2006;35(2):216–220. https://doi.org/10.1016/J.JCV.2005.09.015.CrossRefGoogle ScholarPubMed

Neufeld, MD, Frigon, C, Graham, AS, Mueller, BA. Maternal infection and risk of cerebral palsy in term and preterm infants. J Perinatol. 2005;25(2):108–113. https://doi.org/10.1038/SJ.JP.7211219.CrossRefGoogle ScholarPubMed

Wu, YW, Escobar, GJ, Grether, JK et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003;290(20):2677–2684. https://doi.org/10.1001/JAMA.290.20.2677.CrossRefGoogle ScholarPubMed

Gibson, CS, MacLennan, AH, Goldwater, PN et al. Neurotropic viruses and cerebral palsy: Population based case-control study. BMJ. 2006;332(7533):76–79. https://doi.org/10.1136/BMJ.38668.616806.3A.CrossRefGoogle ScholarPubMed

Pharoah, POD. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F111–F116. https://doi.org/10.1136/FN.84.2.F111.CrossRefGoogle ScholarPubMed

Scher, AI, Petterson, B, Blair, E et al. The risk of mortality or cerebral palsy in twins: A collaborative population-based study. Pediatr Res. 2002;52(5):671–681. https://doi.org/10.1203/00006450-200211000-00011.CrossRefGoogle ScholarPubMed

Glinianaia, SV, Jarvis, S, Topp, M et al. Intrauterine growth and cerebral palsy in twins: A European multicenter study. Twin Res Hum Genet. 2006;9(3):460–466. https://doi.org/10.1375/183242706777591209.CrossRefGoogle ScholarPubMed

Jarvis, S, Glinianaia, SV, Torrioli, MG et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet. 2003;362(9390):1106–1111. https://doi.org/10.1016/S0140-6736(03)14466-2.CrossRefGoogle ScholarPubMed

Reddihough, DS, Collins, KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother. 2003;49(1):7–12. https://doi.org/10.1016/S0004-9514(14)60183-5.CrossRefGoogle ScholarPubMed

Upadhyay, J, Tiwari, N, Ansari, MN. Cerebral palsy: Aetiology, pathophysiology and therapeutic interventions. Clin Exp Pharmacol Physiol. 2020;47(12):1891–1901. https://doi.org/10.1111/1440-1681.13379.CrossRefGoogle ScholarPubMed

Hankins, GDV, Speer, M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynaecol. 2003;102(3):628–636. https://doi.org/10.1016/S0029-7844(03)00574-X.Google ScholarPubMed

Jacquelin Peck, B, Urits, I, Kassem, H et al. Interventional approaches to pain and spasticity related to cerebral palsy. Psychopharmacol Bull. 2020;50(4 Suppl 1):108–120.Google Scholar

Delgado, MR, Hirtz, FD, Aisen, FM et al. Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology. 2010;74(4):336–343.CrossRefGoogle ScholarPubMed

Jacki Peck, B, Urits, I, Crane, J et al. Oral muscle relaxants for the treatment of chronic pain associated with cerebral palsy. Psychopharmacol Bull. 2020;50(4 Suppl 1):142–162.Google Scholar

Sinatra, R, Jahr, J, Watkins-Pitchford, J (Eds.). In The essence of analgesia and analgesics. Cambridge: Cambridge University Press. Published online January 1, 2022. pp. 375–378. https://doi.org/10.1017/CBO9780511841378.094.Google Scholar

Wheeler, AH, Carolina, N. Myofascial pain disorders: Theory to therapy. Drugs. 2004;64(1):45–62.CrossRefGoogle ScholarPubMed

Harden, RN, Bruehl, SP, Gass, S, Niemiec, C, Barbick, B. Signs and symptoms of the myofascial pain syndrome: A national survey of pain management providers. Clin J Pain. 2000;16(1):64–72.CrossRefGoogle ScholarPubMed

Fleckenstein, J, Zaps, D, Rüger, LJ et al. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: Results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010;11:32. doi: 10.1186/1471-2474-11-32.CrossRefGoogle ScholarPubMed

Gerwin, RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep. 2001;5(5):412–420.CrossRefGoogle ScholarPubMed

Vázquez-Delgado, E, Cascos-Romero, J, Gay-Escoda, C. Myofascial pain syndrome associated with trigger points: A literature review. (I): Epidemiology, clinical treatment and etiopathogeny. Med Oral Patol Oral Cir Bucal. 2009;14(10):e494–e498.CrossRefGoogle ScholarPubMed

Lin, WC, Shen, CC, Tsai, SJ, Yang, AC. Increased risk of myofascial pain syndrome among patients with insomnia. Pain Med (United States). 2017;18(8):1557–1565.CrossRefGoogle ScholarPubMed

Bartley, J, Reid, D, Morton, RP. Prevalence of vitamin D deficiency among patients attending a general otolaryngology clinic in South Auckland. Ann Otol Rhinol Laryngol. 2009;118(5):326–328.CrossRefGoogle ScholarPubMed

Vidaković, B, Uljanić, I, Perić, B, Grgurević, J, Sonicki, Z. Myofascial pain of the head and neck among Croatian war veterans treated for depression and posttraumatic stress disorder. Psychiatr Danub. 2016;28(1):73–76.Google ScholarPubMed

Brodsky, M, Spritzer, K, Hays, RD, Hui, KK. Change in health-related quality-of-life at group and individual levels over time in patients treated for chronic myofascial neck pain. J Evidence-Based Complement Altern Med. 2017;22(3):365–368.CrossRefGoogle ScholarPubMed

Celik, D, Mutlu, EK. Clinical implication of latent myofascial trigger point topical collection on myofascial pain. Curr Pain Headache Rep. 2013;17(8):353. doi: 10.1007/s11916-013-0353-8. PMID: 23801006.CrossRefGoogle Scholar

Money, S. Pathophysiology of trigger points in myofascial pain syndrome. J Pain Palliat Care Pharmacother. 2017;31(2):158–159.CrossRefGoogle ScholarPubMed

Baldry, P. Management of myofascial trigger point pain. Acupunct Med. 2002;20(1):2–10.CrossRefGoogle ScholarPubMed

Hong, CZ, Simons, DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil. 1998;79(7):863–872.CrossRefGoogle ScholarPubMed

Simons, DG. Clinical and etiological update of myofascial pain from trigger points. J Musculoskelet Pain. 1996;4(1–2):93–122.CrossRefGoogle Scholar

Juan, FJ. Use of botulinum toxin-A for musculoskeletal pain in patients with whiplash associated disorders [ISRCTN68653575]. BMC Musculoskelet Disord. 2004;5(1):5. doi: 10.1186/1471-2474-5-5. PMID: 15018625; PMCID: PMC356919.CrossRefGoogle ScholarPubMed

Acquadro, MA, Borodic, GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. 1994;80(3):705–706.CrossRefGoogle ScholarPubMed

Zhou, JY, Wang, D. An update on botulinum toxin A injections of trigger points for myofascial pain. Curr Pain Headache Rep. 2014;18(1):386. doi: 10.1007/s11916-013-0386-z. PMID: 24338700.CrossRefGoogle ScholarPubMed

Ge, H-Y, Fernández-de-Las-Peñas, C, Yue, S-W. Myofascial trigger points: Spontaneous electrical activity and its consequences for pain induction and propagation. Chin Med. 2011;6:13. doi: 10.1186/1749-8546-6-13. PMID: 21439050; PMCID: PMC3070691.CrossRefGoogle ScholarPubMed

Simons, DG, Dexter, JR. Comparison of local twitch responses elicited by palpitation and needling of myofascial trigger points. J Musculoskelet Pain. 1995;3(1):49–61.CrossRefGoogle Scholar

Bengtsson, A, Henriksson, KG, Larsson, J. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum. 1986;29(7):817–821.CrossRefGoogle ScholarPubMed

Jafri, MS. Mechanisms of myofascial pain. Int Sch Res Not. 2014;2014:523924. oi: 10.1155/2014/523924. PMID: 25574501; PMCID: PMC4285362.Google ScholarPubMed

Graff-Radford, SB. Myofascial pain: Diagnosis and management. Curr Pain Headache Rep. 2004;8(6):463–467.CrossRefGoogle ScholarPubMed

Thibaut, A, Zeng, D, Caumo, W, Liu, J, Fregni, F. Corticospinal excitability as a biomarker of myofascial pain syndrome. PAIN Rep. 2017;2(3):e594. doi: 10.1097/PR9.0000000000000594. PMID: 29392210; PMCID: PMC5741300.CrossRefGoogle ScholarPubMed

Chen, Q, Basford, J, An, K-N. Ability of magnetic resonance elastography to assess taut bands. Clin Biomech (Bristol, Avon). 2008;23(5):623–629.CrossRefGoogle ScholarPubMed

Fricton, J. Myofascial pain. Oral Maxillofac Surg Clin North Am. 2016;28(3):289–311.CrossRefGoogle ScholarPubMed

Bonder, JH, Chi, M, Rispoli, L. Myofascial pelvic pain and related disorders. Phys Med Rehabil Clin North Am. 2017;28(3):501–515.CrossRefGoogle ScholarPubMed

Do, TP, Heldarskard, GF, Kolding, LT, Hvedstrup, J, Schytz, HW. Myofascial trigger points in migraine and tension-type headache. J Headache Pain. 2018;19(1):84. doi: 10.1186/s10194-018-0913-8. PMID: 30203398; PMCID: PMC6134706.CrossRefGoogle ScholarPubMed

Palacios-Ceña, M, Wang, K, Castaldo, M et al. Trigger points are associated with widespread pressure pain sensitivity in people with tension-type headache. Cephalalgia. 2018;38(2):237–245.CrossRefGoogle ScholarPubMed

Cambron, J. A new era for the Journal of Bodywork and Movement Therapies. J Bodyw Mov Ther. 2019;23(1):1–2.CrossRefGoogle ScholarPubMed

Bajaj, P, Bajaj, P, Graven-Nielsen, T, Arendt-Nielsen, L. Trigger points in patients with lower limb osteoarthritis. J Musculoskelet Pain. 2001;9(3):17–33.CrossRefGoogle Scholar

Henry, R, Cahill, CM, Wood, G et al. Myofascial pain in patients waitlisted for total knee arthroplasty. Pain Res Manag. 2012; 17(5):321–327.CrossRefGoogle ScholarPubMed

Peral-Cagigal, B, Pérez-Villar, Á, Redondo-González, L-M et al. Temporal headache and jaw claudication may be the key for the diagnosis of giant cell arteritis. Med Oral Patol Oral Cir Bucal. 2018;23(3):e290–e294.Google ScholarPubMed

Chiarotto, A, Clijsen, R, Fernandez-De-Las-Penas, C, Barbero, M. Prevalence of myofascial trigger points in spinal disorders: A systematic review and meta-analysis. Presented as an abstract and poster to the World Confederation of Physical Therapy Congress, May 1–4, 2015, Singapore. Arch Phys Med Rehabil. 2016;97(2):316–337.CrossRefGoogle ScholarPubMed

Bourgaize, S, Newton, G, Kumbhare, D, Srbely, J. A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: Implications for differential diagnosis and management. J Can Chiropr Assoc. 2018;62(1):26–41.Google ScholarPubMed

Ajimsha, MS, Al-mudahka, NR. Effectiveness of myofascial release: Systematic review of randomized controlled trials. J Bodyw Mov Ther. 2015;19(1):102–112.CrossRefGoogle ScholarPubMed

Laimi, K, Mäkilä, A, Bärlund, E et al. Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: A systematic review. Clin Rehabil. 2018;32(4):440–450.CrossRefGoogle ScholarPubMed

Ajimsha, MS, Daniel, B, Chithra, S. Effectiveness of myofascial release in the management of chronic low back pain in nursing professionals. J Bodyw Mov Ther. 2014;18(2):273–281.CrossRefGoogle ScholarPubMed

Kalichman, L, Ben David, C. Effect of self-myofascial release on myofascial pain, muscle flexibility, and strength: A narrative review. J Bodyw Mov Ther. 2017;21(2):446–451.CrossRefGoogle ScholarPubMed

Beardsley, C, Škarabot, J. Effects of self-myofascial release: A systematic review. J Bodyw Mov Ther. 2015;19(4):747–758.CrossRefGoogle ScholarPubMed

Liu, L, Huang, QM, Liu, QG et al. Evidence for dry needling in the management of myofascial trigger points associated with low back pain: A systematic review and meta-analysis. Arch Phys Med Rehabil. 2018;99(1):144–152.CrossRefGoogle ScholarPubMed

Espejo-Antúnez, L, Tejeda, JFH, Albornoz-Cabello, M et al. Dry needling in the management of myofascial trigger points: A systematic review of randomized controlled trials. Complement Ther Med. 2017;33:46–57.CrossRefGoogle ScholarPubMed

Rodríguez-Mansilla, J, Gonzalez-Sanchez, B. Effectiveness of dry needling on reducing pain intensity in patients with myofascial pain syndrome: A meta-analysis. J Tradit Chinese Med. 2016;36(1):1–13. doi: 10.1016/s0254-6272(16)30001-2. PMID: 26946612.CrossRefGoogle ScholarPubMed

Furlan, AD, van Tulder, M, Cherkin, D et al. Acupuncture and dry-needling for low back pain: An updated systematic review within the framework of the cochrane collaboration. Spine. 2005;30(8):944–963. doi: 10.1097/01.brs.0000158941.21571.01. PMID: 15834340.CrossRefGoogle ScholarPubMed

Abbaszadeh-Amirdehi, M, Nakhostin Ansari, N, Naghdi, S, Olyaei, G. Neurophysiological and clinical effects of dry needling in patients with upper trapezius myofascial trigger points. J Bodyw Mov Ther. 2017;21(1):48–52.CrossRefGoogle ScholarPubMed

Gerber, LH, Sikdar, S, Aredo, JV et al. Beneficial effects of dry needling for treatment of chronic myofascial pain persist for 6 weeks after treatment completion. PM&R. 2017;9(2):105–112.Google ScholarPubMed

Wang, R, Li, X, Zhou, S et al. Manual acupuncture for myofascial pain syndrome: A systematic review and meta-analysis. Acupunct Med. 2017;35(4):241–250.CrossRefGoogle ScholarPubMed

Mayo Clinic. Acupuncture. 2019. pp. 2–5.Google Scholar

Chou, LW, Hsieh, YL, Chen, HS et al. Remote therapeutic effectiveness of acupuncture in treating myofascial trigger point of the upper trapezius muscle. Am J Phys Med Rehabil. 2011;90(12):1036–1049.CrossRefGoogle ScholarPubMed

Hsieh, Y, Hong, C, Liu, S, Chou, L. Acupuncture at distant myofascial trigger spots enhances endogenous opioids in rabbits: A possible mechanism for managing myofascial pain. Acupunct Med. 2016;34(4):302–309.CrossRefGoogle Scholar

Fan, A, He, H. Dry needling is acupuncture. Acupunct Med. 2016;34(3):241. doi: 10.1136/acupmed-2015-011010. Epub 2015 Dec 15. PMID: 26672062.CrossRefGoogle ScholarPubMed

Gibson, W, Bm, W, Meads, C, Mj, C, Ne, OC. Transcutaneous electrical nerve stimulation (TENS) for chronic pain: An overview of cochrane reviews (Review). Cochrane Database Syst Rev. 2019;2(2):CD011890. doi: 10.1002/14651858.CD011890.pub2.Google ScholarPubMed

Sluka, KA, Bjordal, JM, Marchand, S, Rakel, BA. What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Phys Ther. 2013;93(10):1397–1402.CrossRefGoogle ScholarPubMed

Rodríguez-Fernández, ÁL, Garrido-Santofimi, V, Güeita-Rodríguez, J, Fernández-de-las-Peñas, C. Effects of burst-type transcutaneous electrical nerve stimulation on cervical range of motion and latent myofascial trigger point pain sensitivity. Arch Phys Med Rehabil. 2011;92(9):1353–1358.CrossRefGoogle ScholarPubMed

Gemmell, H, Hilland, A. Immediate effect of electric point stimulation (TENS) in treating latent upper trapezius trigger points: A double blind randomised. J Bodyw Mov Ther. 2011;15(3):348–354.CrossRefGoogle ScholarPubMed

Fuentes, JP, Olivo, SA, Magee, DJ, Gross, DP. Effectiveness of interferential current therapy in the management of musculoskeletal pain: A systematic review and meta-analysis. Phys Ther. 2010;90(9):1219–1238.CrossRefGoogle ScholarPubMed

Albornoz-Cabello, M, Maya-Martín, J, Domínguez-Maldonado, G, Espejo-Antúnez, L, Heredia-rizo, AM. Effect of interferential current therapy on pain perception and disability level in subjects with chronic low back pain: A randomized controlled trial. 2017;31(2):242–249. doi: 10.1177/0269215516639653. Epub 2016 Jul 10. PMID: 26975312.Google Scholar

Cadena de Almeida, C, Maldaner de Silva, VZ, Cipriano Junior, G, Eloin Liebano, R, Joao Luiz, QD. Transcutaneous electrical nerve stimulation and interferential current demonstrate similar effects in relieving acute and chronic pain: A systematic review with meta-analysis. Brazilian J Phys Ther. 2018;22(5):347–354.CrossRefGoogle Scholar

Dissanayaka, T, Pallegama, R, Suraweera, H, Johnson, MI, Kariyawasam, AP. Comparison of the effectiveness of transcutaneous electrical nerve stimulation and interferential therapy on the upper trapezius in myofascial pain syndrome. Am J Phys Med Rehabil. 2016;95(9):663–672.CrossRefGoogle Scholar

Giggins, OM, Persson, UM, Caulfield, B. Biofeedback in rehabilitation. J Neuroeng Rehabil. 2013;10(1):60. doi: 10.1186/1743-0003-10-60. PMID: 23777436; PMCID: PMC3687555.CrossRefGoogle ScholarPubMed

Srinivasan, AK, Kaye, JD, Moldwin, R. Myofascial dysfunction associated with chronic pelvic floor pain: Management strategies. Curr Pain Headache Rep. 2007;11(5):359–364. doi: 10.1007/s11916-007-0218-0. PMID: 17894926.CrossRefGoogle ScholarPubMed

Nestoriuc, Y, Martin, A, Rief, W, Andrasik, F. Biofeedback treatment for headache disorders: A comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125–140.CrossRefGoogle ScholarPubMed

Whelton, A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics. Am J Ther. 2000;7(2):63–74.CrossRefGoogle ScholarPubMed

Laine, L. Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage. 2003;25(2):32–40.CrossRefGoogle ScholarPubMed

Rainsford, K. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med. 1999;107(6):27–35.CrossRefGoogle ScholarPubMed

Cashman, JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52(Suppl 5):13–23.CrossRefGoogle ScholarPubMed

Hsieh, L-F, Hong, C-Z, Chern, S-H, Chen, C-C. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manage. 2010;39(1):116–125.CrossRefGoogle ScholarPubMed

Plesh, O, Curtis, D, Levine, J, McCall, WD. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000;27(10):834–841.CrossRefGoogle ScholarPubMed

Huang-Lionnet, JH, Hameed, H, Cohen, SP. Pharmacologic management of myofascial pain. In Essentials of pain medicine. 4th ed. 2018. pp. 475–484. doi: 10.1016/B978-0-323-40196-8.00053-X.CrossRefGoogle Scholar

Gallagher, RM. Management of neuropathic pain: Translating mechanistic advances and evidence-based research into clinical practice. Clin J Pain. 2006;22(Suppl 1):S2–S8.CrossRefGoogle ScholarPubMed

Obata, H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017;18(11): 2483. doi: 10.3390/ijms18112483.CrossRefGoogle ScholarPubMed

Bendtsen, L, Jensen, R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia. 2000;20(6):603–610.CrossRefGoogle ScholarPubMed

Haviv, Y, Rettman, A, Aframian, D, Sharav, Y, Benoliel, R. Myofascial pain: An open study on the pharmacotherapeutic response to stepped treatment with tricyclic antidepressants and gabapentin. J Oral Facial Pain Headache. 2015;29(2):144–151.CrossRefGoogle Scholar

Haviv, Y, Zini, A, Sharav, Y, Almoznino, G, Benoliel, R. Nortriptyline compared to amitriptyline for the treatment of persistent masticatory myofascial pain. J Oral Facial Pain Headache. 2018;33(1):7–13. doi: 10.11607/ofph.1886.CrossRefGoogle ScholarPubMed

Czarnetzki, C, Elia, N, Lysakowski, C et al. Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children. JAMA. 2008;300(22):2621–2630. doi: 10.1001/jama.2008.794. PMID: 19066382.CrossRefGoogle ScholarPubMed

Annaswamy, TM, De Luigi, AJ, O’Neill, BJ, Keole, N, Berbrayer, D. Emerging concepts in the treatment of myofascial pain: A review of medications, modalities, and needle-based interventions. PM&R. 2011;3(10):940–961.Google Scholar

Heir, GM. The efficacy of pharmacologic treatment of temporomandibular disorders. Oral Maxillofac Surg Clin North Am. 2018;30(3):279–285.CrossRefGoogle ScholarPubMed

McNeill, C. Management of temporomandibular disorders: concepts and controversies. J Prosthet Dent. 1997;77(5):510–522. doi: 10.1016/s0022-3913(97)70145-8. PMID: 9151272.CrossRefGoogle Scholar

Loveless, MS, Fry, AL. Pharmacologic therapies in musculoskeletal conditions. Med Clin North Am. 2016;100(4):869–890.CrossRefGoogle ScholarPubMed

Häggman-Henrikson, B, Alstergren, P, Davidson, T et al. Pharmacological treatment of oro-facial pain: Health technology assessment including a systematic review with network meta-analysis. J Oral Rehabil. 2017;44(10):800–826.CrossRefGoogle ScholarPubMed

Herman, CR, Schiffman, EL, Look, JO, Rindal, DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: A randomized clinical trial. J Orofac Pain. 2002;16(1):64–70.Google ScholarPubMed

Fishbain, DA, Cutler, RB, Rosomoff, HL, Rosomoff, RS. Clonazepam open clinical treatment trial for myofascial syndrome associated chronic pain. Pain Med. 2000;1(4):332–339.CrossRefGoogle ScholarPubMed

Harkins, S, Linford, J, Cohen, J, Kramer, T, Cueva, L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: A double-blind pilot study. J Craniomandib Disord. 1991;5(3):179–186.Google Scholar

Hersh, EV, Balasubramaniam, R, Pinto, A. Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am. 2008;20(2):197–210.CrossRefGoogle ScholarPubMed

Leite, FM, Atallah, ÁN, El Dib, R et al. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev. 2009;(3):CD006830. doi: 10.1002/14651858.CD006830.Google ScholarPubMed

Beebe, FA, Barkin, RL, Barkin, S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther. 2005;12(2):151–171.CrossRefGoogle ScholarPubMed

Ghanavatian, S, Derian, A. Tizanidine. StatPearls; 2018.Google Scholar

Shakespeare, D, Boggild, M, Young, CA. Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev. 2003;(4):CD001332. doi: 10.1002/14651858.CD006830.Google ScholarPubMed

Malanga, GA, Gwynn, MW, Smith, R, Miller, D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician. 2002;5(4):422–432.CrossRefGoogle ScholarPubMed

Groves, L, Shellenberger, MK, Davis, CS. Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv Ther. 1998;15(4):241–251.Google ScholarPubMed

Malanga, G, Reiter, RD, Garay, E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother. 2008;9(12):2209–2215.CrossRefGoogle ScholarPubMed

Jaiswal, M, Sanyal, RP, Goswami, S. Revalidation of trigger point injection in myofascial pain syndrome, assessed by pain disability score. Int J Sci Study. 2017;172.Google Scholar

Xie, P, Qin, B, Yang, F et al. Lidocaine injection in the intramuscular innervation zone can effectively treat chronic neck pain caused by MTrPs in the trapezius muscle. Pain Physician. 2015;18(5):E815–E826.Google ScholarPubMed

Firmani, M, Miralles, R, Casassus, R. Effect of lidocaine patches on upper trapezius EMG activity and pain intensity in patients with myofascial trigger points: A randomized clinical study. Acta Odontol Scand. 2015;73(3):210–218.CrossRefGoogle ScholarPubMed

Affaitati, G, Fabrizio, A, Savini, A et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: Evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31(4):705–720.CrossRefGoogle Scholar

Affaitati, G, Costantini, R, Tana, C et al. Effects of topical vs. injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: A retrospective analysis. J Headache Pain. 2018;19(1):104. doi: 10.1186/s10194-018-0934-3.CrossRefGoogle ScholarPubMed

Borg-Stein, J, Simons, DG. Myofascial pain. Arch Phys Med Rehabil. 2002;83:S40–S47.CrossRefGoogle ScholarPubMed

Awan, KH, Patil, S, Alamir, AWH et al. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. J Oral Pathol Med. 2019;48(3):192–200. doi: 10.1111/jop.12822.CrossRefGoogle ScholarPubMed

Machado, E, Machado, P, Wandscher, VF et al. A systematic review of different substance injection and dry needling for treatment of temporomandibular myofascial pain. Int J Oral Maxillofac Surg. 2018;47(11):1420–1432.CrossRefGoogle ScholarPubMed

Baker, JS, Nolan, PJ. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series. J Am Dent Assoc. 2017;148(1):33–39.CrossRefGoogle ScholarPubMed

Khalifeh, M, Mehta, K, Varguise, N, Suarez-Durall, P, Enciso, R. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome. J Am Dent Assoc. 2016;147(12):959–973.CrossRefGoogle ScholarPubMed

Kwanchuay, P, Petchnumsin, T, Yiemsiri, P et al. Efficacy and safety of single botulinum toxin type A (Botox®) injection for relief of upper trapezius myofascial trigger point: A randomized, double-blind, placebo-controlled study. J Med Assoc Thai. 2015;98(12):1231–1236.Google ScholarPubMed

Halder, GE, Scott, L, Wyman, A et al. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain. Investig Clin Urol. 2017;58(2):134–139. doi: 10.4111/icu.2017.58.2.134.CrossRefGoogle ScholarPubMed

Jahngir, MU, Qureshi, AI. Dejerine Roussy syndrome. StatPearls. Published online July 4, 2022. www.ncbi.nlm.nih.gov/books/NBK519047/.Google Scholar

Klit, H, Finnerup, NB, Jensen, TS. Central post-stroke pain: Clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8(9):857–868. https://doi.org/10.1016/S1474-4422(09)70176-0.CrossRefGoogle ScholarPubMed

Kumar, B, Kalita, J, Kumar, G, Misra, UK. Central poststroke pain: A review of pathophysiology and treatment. Anesth Analg. 2009;108(5):1645–1657. https://doi.org/10.1213/ANE.0B013E31819D644C.CrossRefGoogle Scholar

Delpont, B, Blanc, C, Osseby, GV et al. Pain after stroke: A review. Rev Neurol (Paris). 2018;174(10):671–674. https://doi.org/10.1016/J.NEUROL.2017.11.011.CrossRefGoogle ScholarPubMed

Gasca-González, OO, Pérez-Cruz, JC, Baldoncini, M, Macías-Duvignau, MA, Delgado-Reyes, L. Neuroanatomical basis of Wallenberg syndrome. Cir Cir. 2020;88(3):376–382. https://doi.org/10.24875/CIRU.19000801.Google ScholarPubMed

Canavero, S, Bonicalzi, V. Central pain of brain origin. Central Pain Syndrome. Published online December 24, 2007:9–112. https://doi.org/10.1017/CBO9780511585692.003.CrossRefGoogle Scholar

Leijon, G, Boivie, J, Johansson, I. Central post-stroke pain: Neurological symptoms and pain characteristics. Pain. 1989;36(1):13–25. https://doi.org/10.1016/0304-3959(89)90107-3.CrossRefGoogle ScholarPubMed

Hansen, AP, Marcussen, NS, Klit, H et al. Pain following stroke: A prospective study. Eur J Pain. 2012;16(8):1128–1136. https://doi.org/10.1002/J.1532-2149.2012.00123.X.CrossRefGoogle ScholarPubMed

Akyuz, G, Kuru, P. Systematic review of central post stroke pain. Am J Phys Med Rehabil. 2016;95(8):618–627. https://doi.org/10.1097/PHM.0000000000000542.CrossRefGoogle ScholarPubMed

Zheng, Y, Xu, L, Dong, N, Li, F. NLRP3 inflammasome: The rising star in cardiovascular diseases. Front Cardiovasc Med. 2022;9:927061. doi: 10.3389/fcvm.2022.927061. PMID: 36204568; PMCID: PMC9530053.CrossRefGoogle ScholarPubMed

Whiting, BB, Whiting, AC, Whiting, DM. Thalamic deep brain stimulation. Prog Neurol Surg. 2018;33:198–206. https://doi.org/10.1159/000481104.CrossRefGoogle ScholarPubMed

Kumar, A, Bhoi, SK, Kalita, J, Misra, UK. Central poststroke pain can occur with normal sensation. Clin J Pain. 2016;32(11):955–960. https://doi.org/10.1097/AJP.0000000000000344.CrossRefGoogle ScholarPubMed

Şahin-Onat, Ş, Ünsal-Delialioğlu, S, Kulaklı, F, Özel, S. The effects of central post-stroke pain on quality of life and depression in patients with stroke. J Phys Ther Sci. 2016;28(1):96–101. https://doi.org/10.1589/JPTS.28.96.CrossRefGoogle ScholarPubMed

Paolucci, S, Iosa, M, Toni, D et al. Prevalence and time course of post-stroke pain: A multicenter prospective hospital-based study. Pain Med (United States). 2016;17(5):924–930. https://doi.org/10.1093/PM/PNV019.Google Scholar

Lim, TH, Choi, SI, Yoo, JI et al. Thalamic pain misdiagnosed as cervical disc herniation. Korean J Pain. 2016;29(2):119–122. https://doi.org/10.3344/KJP.2016.29.2.119.CrossRefGoogle ScholarPubMed

Urits, I, Gress, K, Charipova, K et al. Diagnosis, treatment, and management of Dejerine-Roussy syndrome: A comprehensive review. Curr Pain Headache Rep. 2020;24(9):48. https://doi.org/10.1007/S11916-020-00887-3.CrossRefGoogle ScholarPubMed

Chen, CC, Chuang, YF, Huang, ACW, Chen, CK, Chang, YJ. The antalgic effects of non-invasive physical modalities on central post-stroke pain: A systematic review. J Phys Ther Sci. 2016;28(4):1368–1373. https://doi.org/10.1589/JPTS.28.1368.CrossRefGoogle ScholarPubMed

Park, JH, Park, HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9):260. https://doi.org/10.3390/TOXINS9090260.CrossRefGoogle ScholarPubMed

Ward, M, Mammis, A. Deep brain stimulation for the treatment of Dejerine-Roussy syndrome. Stereotact Funct Neurosurg. 2017;95(5):298–306. https://doi.org/10.1159/000479526.CrossRefGoogle ScholarPubMed

Jin, Y, Xing, G, Li, G et al. High frequency repetitive transcranial magnetic stimulation therapy for chronic neuropathic pain: A meta-analysis. Pain Physician. 2015;18(6):E1029–E1046. https://doi.org/10.36076/ppj.2015/18/e1029.Google ScholarPubMed

Morishita, T, Hyakutake, K, Saita, K et al. Pain reduction associated with improved functional interhemispheric balance following transcranial direct current stimulation for post-stroke central pain: A case study. J Neurol Sci. 2015;358(1–2):484–485. https://doi.org/10.1016/J.JNS.2015.08.1551.CrossRefGoogle ScholarPubMed

Bae, SH, Kim, GD, Kim, KY. Analgesic effect of transcranial direct current stimulation on central post-stroke pain. Tohoku J Exp Med. 2014;234(3):189–195. https://doi.org/10.1620/TJEM.234.189.CrossRefGoogle ScholarPubMed

Yamamoto, T, Watanabe, M, Obuchi, T et al. Importance of pharmacological evaluation in the treatment of poststroke pain by spinal cord stimulation. Neuromodulation. 2016;19(7):744–751. https://doi.org/10.1111/NER.12408.CrossRefGoogle ScholarPubMed

Spitoni, GF, Pireddu, G, Galati, G et al. Caloric vestibular stimulation reduces pain and somatoparaphrenia in a severe chronic central post-stroke pain patient: A case study. PLoS One. 2016;11(3):e0151213. https://doi.org/10.1371/JOURNAL.PONE.0151213.CrossRefGoogle Scholar

Liao, C, Yang, M, Liu, P, Zhong, W, Zhang, W. Thalamic pain alleviated by stellate ganglion block: A case report. Medicine. 2017;96(5):e6058. https://doi.org/10.1097/MD.0000000000006058.CrossRefGoogle ScholarPubMed

Sabo, CM, Grad, S, Dumitrascu, DL. Chronic abdominal pain in general practice. Dig Dis. 2021;39(6):606–614. https://doi.org/10.1159/000515433.CrossRefGoogle ScholarPubMed

Lukic, S, Mijac, D, Filipovic, B et al. Chronic abdominal pain: Gastroenterologist approach. Dig Dis. 2022;40(2):181–186. https://doi.org/10.1159/000516977.CrossRefGoogle ScholarPubMed

El-Metwally, A, Shaikh, Q, Aldiab, A et al. The prevalence of chronic pain and its associated factors among Saudi Al-Kharj population; a cross sectional study. BMC Musculoskelet Disord. 2019;20(1):177. https://doi.org/10.1186/S12891-019-2555-7.CrossRefGoogle ScholarPubMed

Jackson, T, Thomas, S, Stabile, V et al. Chronic pain without clear etiology in low- and middle-income countries: A narrative review. Anesth Analg. 2016;122(6):2028–2039. https://doi.org/10.1213/ANE.0000000000001287.CrossRefGoogle ScholarPubMed

Jackson, T, Thomas, S, Stabile, V et al. A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low- and middle-income countries: Trends in heterogeneous data and a proposal for new assessment methods. Anesth Analg. 2016;123(3):739–748. https://doi.org/10.1213/ANE.0000000000001389.CrossRefGoogle Scholar

Koop, H, Koprdova, S, Schürmann, C. Chronic Abdominal Wall Pain: A Poorly Recognized Clinical Problem. Dtsch Arztebl Int. 2016;113:51–57. www.aerzteblatt.de/int/archive/article/173620/Chronic-abdominal-wall-pain-a-poorly-recognized-clinical-problem.Google Scholar

Aziz, Q, Giamberardino, MA, Barke, A et al. The IASP classification of chronic pain for ICD-11: Chronic secondary visceral pain. Pain. 2019;160(1):69–76. https://doi.org/10.1097/J.PAIN.0000000000001362.CrossRefGoogle ScholarPubMed

Wilson, PR. Chronic abdominal pain: An evidence-based, comprehensive guide to clinical management. Pain Med. 2015;16(12):2412–2413. https://doi.org/10.1111/PME.12849.CrossRefGoogle Scholar

Stemboroski, L, Schey, R. Treating chronic abdominal pain in patients with chronic abdominal pain and/or irritable bowel syndrome. Gastroenterol Clin North Am. 2020;49(3):607–621. https://doi.org/10.1016/J.GTC.2020.05.001.CrossRefGoogle ScholarPubMed

Camilleri, M. Management options for irritable bowel syndrome. Mayo Clin Proc. 2018;93(12):1858–1872. https://doi.org/10.1016/J.MAYOCP.2018.04.032.CrossRefGoogle ScholarPubMed

Pichetshote, N, Pimentel, M. An approach to the patient with chronic undiagnosed abdominal pain. Am J Gastroenterol. 2019;114(5):726–732. https://doi.org/10.14309/AJG.0000000000000130.CrossRefGoogle Scholar

Cornman-Homonoff, J, Holzwanger, DJ, Lee, KS, Madoff, DC, Li, D. Celiac plexus block and neurolysis in the management of chronic upper abdominal pain. Semin Intervent Radiol. 2017;34(4):376–386. https://doi.org/10.1055/S-0037-1608861.CrossRefGoogle ScholarPubMed